Probably Genetic
ActivePatient Intelligence Platform for Genetic Disease
This company has previously operated under “Aiwa Health”. A rename frequently marks a pivot in positioning or product — useful raw material for variant ideas.
About
Probably Genetic is changing the lives of patients living with severe, complex diseases. Our data platform is used by drug developers and patient advocacy groups to develop and launch treatments for these patients. Our technology discovers undiagnosed patients online, analyzes their disease state using machine learning and at-home testing, and enables compliant communication with patients. In doing so, we help patients access diagnoses, clinical trials, and treatments as early as possible.
Founders · 1
CEO & Co-Founder of Probably Genetic. Previously BCG & The Bill & Melinda Gates Foundation. PhD from Oxford as a Rhodes Scholar.
Related startups
AI platform accelerating therapies for rare & inflammatory diseases.
Discovering the true signals of disease to power life-changing drugs.
